henhaobio
Sign in

Science AdvancesMicrobiologyPeer-reviewed journal article

Strain-Specific Epistasis Shapes Fitness Landscapes of APOBEC3G Antagonism By HIV-1 Vif Proteins

Caroline A. LangleyiD, Michelle LillyiD, Harmit Singh MalikiD, Michael EmermaniD

PDFDOIPreprint

Abstract

Host immune factors shape viral evolution. The HIV-1 Vif protein counteracts host APOBEC3G (A3G) to ensure productive infection. Using deep mutational scanning (DMS) across two divergent HIV-1 Vif proteins, we systematically mapped and compared the mutational landscapes governing Vif antagonism of A3G. These high-resolution fitness maps reveal core principles of host-virus coevolution. Most missense mutations were strongly deleterious, reflecting pervasive purifying selection. Yet several highly conserved Vif residues at binding interfaces with A3G, RNA, and CBF{beta} exhibited unexpected mutational tolerance, indicating structural flexibility at these sites. Comparative analysis revealed that strain-specific epistasis dictates Vif-A3G interactions, including adaptive changes at the Vif-A3G interface. Further analysis uncovered striking temporal epistasis, whereby initially adaptive Vif mutations critical for antagonizing hominoid A3G subsequently exhibited reduced fitness. Thus, structural robustness permits adaptation, while epistasis imposes constraints on Vifs ability to maintain A3G antagonism while remaining responsive to new evolutionary pressures. TeaserMapping how HIV-1 evolves to outsmart a key human antiviral protein reveals both unexpected flexibility and evolutionary constraints in viral adaptation.

Citations
1
FWCI
4.00
Field percentile
top 6%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISChesarino '21Ronayne '26Haddox '17Shimizu '26Garcia '18Gaba '25
81% semantic matchEvolutionary Biology
N. M. Chesarino, M. Emerman·bioRxiv·Aug 23, 2021